Low-Dose Decitabine Augments the Activation and Anti-Tumor Immune Response of IFN-γ+ CD4+ T Cells Through Enhancing IκBα Degradation and NF-κB Activation

Low-Dose Decitabine Augments the Activation and Anti-Tumor Immune Response of IFN-γ+ CD4+ T Cells Through Enhancing IκBα Degradation and NF-κB Activation

BackgroundCD4+ T cells play multiple roles in controlling tumor growth and increasing IFN-γ+ T-helper 1 cell population could promote cell-mediated anti-tumor immune response. We have previously showed that low-dose DNA demethylating agent decitabine therapy promotes CD3+ T-cell proliferation and cy...

Full description

Bibliographic Details
Main Authors:	Xiang Li, Liang Dong, Jiejie Liu, Chunmeng Wang, Yan Zhang, Qian Mei, Weidong Han, Ping Xie, Jing Nie
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	decitabine CD4+ T cells immune response NF-κB activation IκBα degradation
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2021.647713/full

Similar Items

At the crossroads of SUMO and NF-κB
by: Schmidt Christian, et al.
Published: (2003-11-01)

NF-κB and Its Regulators During Pregnancy
by: Fernando Gómez-Chávez, et al.
Published: (2021-05-01)

Mollugin Has an Anti-Cancer Therapeutic Effect by Inhibiting TNF-α-Induced NF-κB Activation
by: Zhe Wang, et al.
Published: (2017-07-01)

Suppression of NF-κB Activity: A Viral Immune Evasion Mechanism
by: Liyao Deng, et al.
Published: (2018-08-01)

NF-κB in Hematological Malignancies
by: Véronique Imbert, et al.
Published: (2017-05-01)

Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
by: Andrew Paul, et al.
Published: (2018-10-01)

Reduced IκB-α Protein Levels in Peripheral Blood Cells of Patients with Multiple Sclerosis—A Possible Cause of Constitutive NF-κB Activation
by: Jun Yan, et al.
Published: (2020-08-01)

Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis
by: Xin Li, et al.
Published: (2021-03-01)

The Ubiquitination of NF-κB Subunits in the Control of Transcription
by: Patricia E. Collins, et al.
Published: (2016-05-01)

NF-κB Members Left Home: NF-κB-Independent Roles in Cancer
by: Carlota Colomer, et al.
Published: (2017-05-01)

The interaction between miRNAs/lncRNAs and nuclear factor-κB (NF-κB) in human disorders
by: Soudeh Ghafouri-Fard, et al.
Published: (2021-06-01)

Natural Germacrane Sesquiterpenes Inhibit Osteoclast Formation, Bone Resorption, RANKL-Induced NF-κB Activation, and IκBα Degradation
by: Shengnan Qin, et al.
Published: (2015-11-01)

Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity
by: Federica Begalli, et al.
Published: (2017-08-01)

Aloin Suppresses Lipopolysaccharide-Induced Inflammatory Response and Apoptosis by Inhibiting the Activation of NF-κB
by: Xuan Luo, et al.
Published: (2018-02-01)

NF-κB-Dependent and -Independent (Moonlighting) IκBα Functions in Differentiation and Cancer
by: Lluís Espinosa, et al.
Published: (2021-09-01)

NFκB signaling in alveolar rhabdomyosarcoma
by: Megan M. Cleary, et al.
Published: (2017-09-01)

The Regulation of NF-κB Subunits by Phosphorylation
by: Frank Christian, et al.
Published: (2016-03-01)

DNA Damage Signalling in BRCA1-Deficient Mammary Progenitor Cells Activates Autologous p52/RelB NF-κB
by: Sau, Andrea
Published: (2015)

Comparison of the Potency of Pterostilbene with NF-κB Inhibitors in Platelet Activation: Mutual Activation by Akt-NF-κB Signaling in Human Platelets
by: Chih-Wei Hsia, et al.
Published: (2021-07-01)

Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
by: Yifan Zhou, et al.
Published: (2020-03-01)

Synthesis and Identification of Novel Berberine Derivatives as Potent Inhibitors against TNF-α-Induced NF-κB Activation
by: Yan-Xiang Wang, et al.
Published: (2017-07-01)

4′,6-Dihydroxy-4-methoxyisoaurone inhibits TNF-α-induced NF-κB activation and expressions of NF-κB-regulated target gene products
by: Juan Ma, et al.
Published: (2016-02-01)

Osteopontin Promotes Bone Destruction in Periapical Periodontitis by Activating the NF-κB Pathway
by: Ming Dong, et al.
Published: (2018-09-01)

Food Additive Sodium Benzoate (NaB) Activates NFκB and Induces Apoptosis in HCT116 Cells
by: Betul Yilmaz, et al.
Published: (2018-03-01)

Review: NF-κB pathways in the pathogenesis of Multiple Sclerosis and the therapeutic implications
by: Saskia Michaela Leibowitz, et al.
Published: (2016-09-01)

Human primed ILCPs support endothelial activation through NF-κB signaling
by: Giulia Vanoni, et al.
Published: (2021-02-01)

Beyond NF-κB activation: nuclear functions of IκB kinase α
by: Huang Wei-Chien, et al.
Published: (2013-01-01)

NF-κB sub-pathways and HIV cure: A revisit
by: Lilly M. Wong, et al.
Published: (2021-01-01)

Who’s Driving? Human Cytomegalovirus, Interferon, and NFκB Signaling
by: Christopher M. Goodwin, et al.
Published: (2018-08-01)

NF-κB Signaling Pathways in Osteoarthritic Cartilage Destruction
by: Moon-Chang Choi, et al.
Published: (2019-07-01)

Role of NF-κB in Platelet Function
by: Kevin Kojok, et al.
Published: (2019-08-01)

Human Caspase 12 Enhances NF-κB Activity through Activation of IKK in Nasopharyngeal Carcinoma Cells
by: Shu-Er Chow, et al.
Published: (2021-04-01)

Regulation of activation of NF-κB by Calmodulin in T-lymphocytes
by: Oruganti, Sreenivasa Rao
Published: (2011)

Aldosterone induces inflammatory cytokines in penile corpus cavernosum by activating the NF-κB pathway
by: Fei Wu, et al.
Published: (2018-01-01)

Anaplasma phagocytophilum Activates NF-κB Signaling via Redundant Pathways
by: J. Stephen Dumler, et al.
Published: (2020-10-01)

Role of NF- κ B signaling pathway in airway inflammation of rats induced by atmospheric PM25
by: Ru-xuan Zhang, et al.
Published: (2018-01-01)

Loss of NF-κB p50 function synergistically augments microglial priming in the middle-aged brain
by: Thomas Taetzsch, et al.
Published: (2019-03-01)

The Role of bFGF in the Excessive Activation of Astrocytes Is Related to the Inhibition of TLR4/NFκB Signals
by: Libing Ye, et al.
Published: (2015-12-01)

Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model
by: Shinya Morita, et al.
Published: (2020-08-01)

Myostatin Promotes Osteoclastogenesis by Regulating Ccdc50 Gene Expression and RANKL-Induced NF-κB and MAPK Pathways
by: Xin Zhi, et al.
Published: (2020-11-01)